Cargando…
TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells
TMPRSS2:ERG (T/E) gene fusions are present in approximately 50% of all prostate cancer (PCa) cases. The expression of fusion mRNAs from distinct T/E variants is associated with clinicopathological parameters, while the underlying molecular processes remain unclear. We characterized the molecular mec...
Autores principales: | Ratz, Leonie, Laible, Mark, Kacprzyk, Lukasz A, Wittig-Blaich, Stephanie M, Tolstov, Yanis, Duensing, Stefan, Altevogt, Peter, Klauck, Sabine M, Sültmann, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421914/ https://www.ncbi.nlm.nih.gov/pubmed/28445989 http://dx.doi.org/10.18632/oncotarget.15931 |
Ejemplares similares
-
miR-449a Repression Leads to Enhanced NOTCH Signaling in TMPRSS2:ERG Fusion Positive Prostate Cancer Cells
por: Bauer, Simone, et al.
Publicado: (2021) -
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
por: Brase, Jan C, et al.
Publicado: (2011) -
ERG Induces Epigenetic Activation of Tudor Domain-Containing Protein 1 (TDRD1) in ERG Rearrangement-Positive Prostate Cancer
por: Kacprzyk, Lukasz A., et al.
Publicado: (2013) -
Genome-Based Classification and Therapy of Prostate Cancer
por: Angeles, Arlou Kristina, et al.
Publicado: (2018) -
Novel RNA Markers in Prostate Cancer: Functional Considerations and Clinical Translation
por: Pickl, Julia M. A., et al.
Publicado: (2014)